E

EsquireTek

The models carry the step that starts the product's core workflow, on a discovery platform whose other tools would run without them. Alpha, the software a firm operates itself, is described as a do it yourself solution that completes discovery with AI assistance: EsquireTek says its AI scans and extracts the opposing party's discovery requests and creates a response shell within 60 seconds, which becomes a web based form for drafting, client answers and service.

Around that step sit tools that do not depend on models: a library of objections added with one click, client questionnaires sent by text and email whose answers populate the responses, verifications and electronic service. EsquireTek's post of March 2025 on AI in discovery describes the platform as auto generating responses and objections. Omega and the Mass Torts offering add AI supported drafting, chronologies and quality checks, delivered by EsquireTek's staff as a service. In the software a firm buys, the models are the engine of intake and drafting rather than the whole product.

Accuracy is asserted without measurement for a product that drafts discovery responses. The Alpha and document automation pages say EsquireTek's AI accurately scans and extracts discovery requests within 60 seconds, with no error rate, test or description of what happens when a request is misread. The post of March 2025 says the platform auto generates responses and objections and builds accurate medical chronologies, again without a figure or method.

The terms make attorney users responsible for reviewing and revising documents, templates and citations the service provides, which acknowledges that citations come out of the product, and nothing describes where objection language or citations come from or how they are checked. A lawyer has to check every extracted request and objection against the source documents, and the vendor publishes nothing that would tell them how often that check will find an error.

A written allocation puts the lawyer in charge of every output, with an editable document as the review surface. Section 6 of the terms, effective 28 May 2025, says an attorney user is responsible for reviewing and revising any documents, templates or citations provided through the services. In Alpha the extracted requests become a web based form the firm drafts in and edits, client answers populate the responses and can be reviewed and edited before use, and the firm prints and serves.

EsquireTek's post of March 2025 says attorneys stay in control and human review adds context, judgment and strategy. Omega delivers attorney ready discovery for the firm's review and approval, prepared by EsquireTek's team with AI support and human review. What is not published is the rest of the control structure: what the AI may not do, how a misread request is caught before a response is built on it, or what review EsquireTek's own staff apply in Omega and Mass Torts.

Named individuals endorse the product, most without their firms, and the one figure has no basis. The Alpha page carries five testimonials: Robert Simon of Simon Law Group, whose firm is said to have saved countless hours, and four others identified by name and title only, a litigation paralegal, a founding partner, a managing partner and a senior paralegal. The quotes describe time saved and changed work without figures, dates or matters.

The page claims up to 70% faster client response times with no customer, period or method. The Mass Torts page quotes an unnamed partner at a major law firm. MyCase's own article on the integration names no customer. No case study, customer count or dated result is published on the site. A firm can contact one named firm, and cannot read what changed for any customer.

Confidentiality is asserted in general terms, and the agreement grants a broad license over user content. The privacy policy, updated 28 May 2025, says EsquireTek encrypts data in transfer and storage and limits access through access controls and confidentiality commitments. It says data may be accessed or processed by its offices in the United States and by service providers in the United States and India. The terms of the same date grant EsquireTek a perpetual, irrevocable, transferable, royalty free, worldwide and sublicensable license to use, copy, modify, create derivative works from and distribute user content in connection with its business, and contain no confidentiality obligation running to the customer.

Training, privilege, work product and the handling of client medical records are not addressed. Nothing states whether client answers and medical records sent through the platform stay with EsquireTek or reach its providers abroad. Omega and the medical summaries add EsquireTek's staff, including an overseas team described in the FAQ, to the people who handle client material.

The terms draw the advice line and assign review to the attorney, without the supervision questions the service raises. Section 6 of the terms, effective 28 May 2025, says the information provided does not constitute legal advice and tells users to contact an attorney for advice on a particular matter. It makes an attorney user responsible for reviewing and revising any documents, templates or citations the service provides.

The products are sold to trial lawyers, litigation firms and corporate legal teams. The managed offerings raise professional responsibility questions that are not addressed. Omega has EsquireTek's team prepare discovery responses and objections for a firm, and the FAQ describes a team of lawyers overseas preparing medical summaries. Nothing addresses the firm's duty to supervise that work, who on EsquireTek's side is a lawyer and where licensed, or how the arrangement fits rules on assistance from people outside the firm. No ethics opinion is named on any page read.

No governance position on the AI is published. Checked the home, Alpha, Omega, Mass Torts, document automation, client response automation, company and FAQ pages, the terms, the privacy policy and the post of March 2025 on AI in discovery: none names a person accountable for model behavior, describes testing before release, publishes evaluation results, or sets out principles for how the AI is built and used. The post says the best AI tools are built for collaboration rather than replacement, which is a view on use rather than a governance commitment.

The Mass Torts page mentions AI quality signals that warn before submission, without describing what they test. Uneven output is a live question for a product that reads discovery requests from many courts and summarizes medical records, and nothing published addresses it.

A general privacy policy covers the platform without saying what happens to case documents after processing. The privacy policy, updated 28 May 2025, covers website visitors and attorney customers, says data is encrypted in transfer and storage and access is limited by access controls and confidentiality commitments, names Stripe, Google Analytics, Google Ads and Facebook Pixel among the services it uses, and says service providers in the United States and India may process data.

It states no retention period and no deletion commitment. The FAQ says the platform was developed with CIS benchmarks and is HIPAA compliant, and the Alpha page calls it HIPAA certified, without describing the controls or a business associate agreement. The terms contain no data processing terms, breach notice or deletion on exit. Nothing published says how long discovery documents, client answers, medical records or AI outputs are kept, or which providers process them.

Liability is addressed only through a limitation clause, with no vendor indemnity and the exposure placed on the customer. The terms, effective 28 May 2025, provide the services as is without warranties of any kind, and cap EsquireTek's liability at the fees paid in the two months before the event giving rise to a claim, or one hundred US dollars where no fees apply. The customer indemnifies EsquireTek for losses arising from its content, its misuse of the services or its violations; no indemnity runs from EsquireTek.

Disputes go to binding arbitration under Delaware law with a class action waiver, and a separate clause sets liquidated damages of one million dollars for access by competitors or misappropriation of information. Nothing addresses who bears the loss when an extracted request is wrong, an objection is misapplied or a managed Omega response contains an error, though section 6 makes the attorney responsible for reviewing what the service provides.

One practice management integration is documented with what it moves, and no other is named. EsquireTek's MyCase page says the integration shares data between the platforms, and MyCase's own article, updated 21 July 2025, says it syncs MyCase document and case data with EsquireTek to eliminate duplicate data entry, and describes extracted requests converted to editable documents, client questionnaires sent by text, answers populating the responses and finished documents converted to the firm's chosen format.

Within EsquireTek, verifications and electronic service are built into the workflow. No integration with other case management systems, document management systems or court filing systems is published on the pages read, and no setup documentation is public.

Delivery is a web platform, and neither hosting, tenancy nor storage region is stated. The product is used through a web based form and portal, and the pages read describe no deployment options. The privacy policy, updated 28 May 2025, says data may be accessed, shared or processed by EsquireTek's offices in the United States and by service providers in the United States and India, which tells a buyer that people outside the United States may handle its data, without saying where case documents are stored or which provider hosts them.

Nothing states whether customers share infrastructure, which cloud provider is used, where the AI processes discovery requests or medical records, or whether a firm can require storage in the United States.

Security claims appear without an independent attestation behind them. The Alpha page calls the platform HIPAA certified and developed with CIS benchmarks, and the FAQ says it was developed with CIS benchmarks and that HIPAA compliance ensures privacy protection. Neither claim names an assessor, a scope, a date or a report. No SOC 2 report, ISO certification, penetration test or trust center is published on the home, Alpha, Omega, FAQ or company pages, in the terms or in the privacy policy, read.

The privacy policy describes encryption and access controls in general terms. A buyer handling client medical records has a certification claim to ask about and no evidence to read.

The AI is described in general terms and nothing is said about what sits underneath. EsquireTek's pages refer to its groundbreaking AI technology, litigation specific AI and AI assisted drafting, without naming a model, a provider, whether the models are its own or licensed, or where they run. The privacy policy names payment and analytics services and says service providers in the United States and India may process data, without identifying any AI provider.

No commitment to notify customers of a model change is published. A firm cannot tell which provider receives its clients' discovery and medical records when the AI reads them.

Structure is published for the services and no figure for anything. The Omega page says the managed service is priced per token, each token covering one set of discovery, with introductory and volume pricing from the sales team. The Mass Torts page names three tiers, Portal Only, Complaints Only and Full Service, with custom pricing based on firm size, case volume and requirements. EsquireTek's MyCase page describes simple, scalable plans with no contracts.

No price is published for Alpha, Omega or Mass Torts, and the pricing address opens the home page. A firm can see how the services are counted, and cannot learn what the software or a set of discovery costs without a demo.

Who EsquireTek serves is described with substance, and the boundaries are not. The site addresses trial lawyers, litigation firms and corporate legal teams, and its products are built around plaintiff work: written discovery responses with client questionnaires in Alpha; Omega, discovery as a service for personal injury firms covering responses, objections, medical chronologies, Howell charts and exhibits; and Mass Torts for plaintiff fact sheets, damages questionnaires and short form complaints at volume.

What is not stated is which courts and jurisdictions the extraction, objections and response formats support, whether defense firms and corporate teams use the same workflow, and which languages client questionnaires support. A plaintiff firm can see the product was built for its work, and cannot confirm that its jurisdiction is covered.